Table 5 Risk factors assessment for HCV infection
| Â | Â | Â | Genotype | Total | |||||
|---|---|---|---|---|---|---|---|---|---|
Risk factors | Â | Â | 1a | 1b | 3a | 3b | Mixed | Untypable | |
| Â | Barbers | Count | 6 | 1 | 31 | 3 | 5 | 14 | 60 |
% prevalence within Risk factor | 10.0% | 1.7% | 51.7% | 5.0% | 8.3% | 23.3% | 100.0% | ||
% prevalence within Genotype | 40.0% | 11.1% | 15.5% | 12.0% | 22.7% | 31.1% | 19.0% | ||
Blood transfusion | Count | 3 | 4 | 23 | 6 | 11 | 4 | 51 | |
% prevalence within Risk factor | 5.9% | 7.8% | 45.1% | 11.8% | 21.6% | 7.8% | 100.0% | ||
% prevalence within Genotype | 20.0% | 44.4% | 11.5% | 24.0% | 50.0% | 8.9% | 16.1% | ||
Medical surgeries | Count | 5 | 2 | 45 | 9 | 2 | 14 | 77 | |
% prevalence within Risk factor | 6.5% | 2.6% | 58.4% | 11.7% | 2.6% | 18.2% | 100.0% | ||
% prevalence within Genotype | 33.3% | 22.2% | 22.5% | 36.0% | 9.1% | 31.1% | 24.4% | ||
Needles/syringes | Count | 0 | 2 | 88 | 5 | 4 | 7 | 106 | |
% prevalence within Risk factor | 0.0% | 1.9% | 83.0% | 4.7% | 3.8% | 6.6% | 100.0% | ||
% prevalence within Genotype | 0.0% | 22.2% | 44.0% | 20.0% | 18.2% | 15.6% | 33.5% | ||
Unknown | Count | 1 | 0 | 14 | 2 | 0 | 5 | 22 | |
% prevalence within Risk factor | 4.5% | 0.0% | 63.6% | 9.1% | 0.0% | 22.7% | 100.0% | ||
% prevalence within Genotype | 6.7% | 0.0% | 7.0% | 8.0% | 0.0% | 11.11% | 7.0% | ||
| Â | Total count | 15 | 9 | 200 | 25 | 22 | 45 | 316 | |
% prevalence within Risk factor | 4.7% | 2.8% | 63.3% | 7.9% | 7.0% | 14.2% | 100.0% | ||
p-value for within Genotype risk comparison | N/Aa | N/Aa | 0.000 | 0.199 | 0.042b | 0.044 | 100.0% | ||